iScience (Jan 2024)

SARS-CoV-2 produces a microRNA CoV2-miR-O8 in patients with COVID-19 infection

  • Elise J. Tucker,
  • Soon Wei Wong,
  • Shashikanth Marri,
  • Saira Ali,
  • Anthony O. Fedele,
  • Michael Z. Michael,
  • Darling Rojas-Canales,
  • Jordan Y. Li,
  • Chuan Kok Lim,
  • Jonathan M. Gleadle

Journal volume & issue
Vol. 27, no. 1
p. 108719

Abstract

Read online

Summary: Many viruses produce microRNAs (miRNAs), termed viral miRNAs (v-miRNAs), with the capacity to target host gene expression. Bioinformatic and cell culture studies suggest that SARS-CoV-2 can also generate v-miRNAs. This patient-based study defines the SARS-CoV-2 encoded small RNAs present in nasopharyngeal swabs of patients with COVID-19 infection using small RNA-seq. A specific conserved sequence (CoV2-miR-O8) is defined that is not expressed in other coronaviruses but is preserved in all SARS-CoV-2 variants. CoV2-miR-O8 is highly represented in nasopharyngeal samples from patients with COVID-19 infection, is detected by RT-PCR assays in patients, has features consistent with Dicer and Drosha generation as well as interaction with Argonaute and targets specific human microRNAs.

Keywords